Vanguard Global Advisers »

Kymera Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 27k 83.29

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
BVF
BlackRock
Atlas Venture Life Science Advisors
Wellington Management Company
Siren
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management

View all funds holding Kymera Therapeutics